Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
3 Cards in this Set
- Front
- Back
Although pediatrics represent around two-fifths of the global population the market for pediatric medicines remains relatively small (accounting for <10% of global pharmaceutical sales). Until pediatric legislation was introduced in the US (1997) and EU (2007) there has been little incentive for the pharma industry to evaluate drugs in children due to the low medical need of chronic illnesses and the high off-label use of generic drugs (Milne & Bruss, 2008).
To Brows a Full Report with Toc: http://www.researchmoz.us/pediatric-drug-development-regulatory-challenges-and-commercial-opportunities-report.html |
To Brows a Full Report with Toc: http://www.researchmoz.us/pediatric-drug-development-regulatory-challenges-and-commercial-opportunities-report.html |
|
Assesses what issues need to be addressed in order to improve access to pediatric medicines and commercial opportunities in transition countries based on KOL insights; Analyses different strategies to develop age-appropriate medicines in niche therapeutic fields in neonates, rare and neglected pediatric diseases and pediatric vaccines.
All Repoers of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html |
All Repoers of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html |
|
About ResearchMoz
Email: sales@researchmoz.us Website @ http://www.researchmoz.us/ |
Contact US:
Email: sales@researchmoz.us Website @ http://www.researchmoz.us/ |